MARKET

ZLSCF

ZLSCF

Zyus Life Sciences Corporation
OTCPK
0.650
NaN%
Closed 09:30 10/02 EDT
OPEN
--
PREV CLOSE
0.650
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.650
52 WEEK LOW
0.480
MARKET CAP
52.34M
P/E (TTM)
-3.7659
1D
5D
1M
3M
1Y
5Y
1D
ZYUS Life Sciences cancels brokered offering, plans C$7M private placement, expands credit facility
Seeking Alpha · 02/25 12:52
About ZLSCF
ZYUS Life Sciences Corporation is a Canada-based life sciences company focused on developing and commercializing cannabinoid-based pharmaceutical drug candidates for pain management. Its lead research program is focused on developing a purified cannabinoid formulation to treat chronic pain due to cancer, musculoskeletal injuries and arthritis. Its lead/first drug product candidate in this program, Trichomylin softgel capsules, is a fixed dose combination of cannabinoids formulated for the treatment of chronic pain in adults. This formulation offers oral administration of highly purified cannabinoids in a controlled dosage. In parallel with the research conducted respecting Trichomylin softgel capsules, it has also identified and commenced research on a second drug candidate. This drug candidate is a cannabinoid-based therapeutic composition for pain management. Both pre-clinical and non-clinical studies have been conducted on this formulation and patent applications have been filed.

Webull offers ZYUS Life Sciences Corp stock information, including OTCPK: ZLSCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLSCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLSCF stock methods without spending real money on the virtual paper trading platform.